Curapath is a European Contract Development and Manufacturing Organization (CDMO) specialized in lipid- and polymer-based delivery systems. We support biotech and pharmaceutical companies from early development through GMP-ready manufacturing.

Our core expertise includes polymer and lipid excipients, lipid nanoparticles (LNPs), polymer nanoparticles (PNPs), polymer–drug conjugates, and coating polymers.

 Curapath provides integrated CDMO services covering drug substance (DS) and drug product (DP) development, GMP manufacturing of lipids and polymers, nanoparticle formulation, analytical development, quality control, and aseptic Fill & Finish operations. 

More abour our end-to-end services

Yes. We support advanced therapeutic modalities including RNA-based medicines, cell and gene therapies, and non-viral delivery platforms requiring specialized carrier systems and GMP-aligned manufacturing.

Our experience includes support for programs such as in vivo gene editing approaches, RNA therapeutics, and emerging strategies like in vivo CAR-T platforms enabled by lipid nanoparticle (LNP) delivery. We also develop PEG-alternative shielding systems, including polysarcosine-based lipids and polymers, designed to improve safety profile and enable repeat dosing strategies.

Each program is supported through integrated drug substance, drug product, and analytical development workflows to ensure scalability and regulatory readiness.

 Yes. Our integrated analytical services include method development, validation, stability studies, and quality control testing to support regulatory submissions and GMP manufacturing. 

Quality development aligned qwith each market regulatory requirements:

• Controlled rooms for medical-device ingredients
• ICH Q11-guided excipient development
• GMP / ICH Q7-aligned drug-substance manufacturing

Yes. We offer aseptic Fill & Finish operations for advanced therapeutics, supporting clinical-stage programs and regulatory-aligned production requirements.

Our capabilities include multiple sterile formats such as glass vials (various fill volumes and configurations), bottles, prefilled syringes, and flexible bags. We support both liquid and lyophilized presentations depending on product requirements.

Fill & Finish operations are performed within controlled cleanroom environments, with integrated environmental monitoring, sterility assurance, and Qualified Person (QP) release processes to ensure compliance with GMP standards.

 You can initiate a discussion by contacting our team  After reviewing your modality, development stage, and target specifications, we will propose a tailored technical and manufacturing pathway. 

We will be happy to discuss your needs and how we can help you, you can send the details  here